Literature DB >> 1979045

Sexual side effects of antipsychotic medication: evaluation and interventions.

G Sullivan1, D Lukoff.   

Abstract

Sexual side effects of antipsychotic medications, which include disturbances of erection and ejaculation, changes in libido, and priapism in men and decreased libido, orgasmic dysfunction, and menstrual irregularities in women, are estimated to occur in 30 to 60 percent of persons taking the drugs. The authors review side effects associated with specific drugs and present guidelines for assessing whether sexual dysfunction is related to medication. Pharmacological interventions that may reduce antipsychotic-induced sexual dysfunction include gradually reducing the dose or changing the type of medication and administering other medications such as bethanechol, neostigmine, cyproheptadine, and bromocriptine that are known to improve sexual dysfunction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979045     DOI: 10.1176/ps.41.11.1238

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  10 in total

1.  Hyperprolactinaemia caused by antipsychotic drugs.

Authors:  Angelika Wieck; Peter Haddad
Journal:  BMJ       Date:  2002-02-02

Review 2.  The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings.

Authors:  Marrit K de Boer; Stynke Castelein; Durk Wiersma; Robert A Schoevers; Henderikus Knegtering
Journal:  Schizophr Bull       Date:  2015-02-25       Impact factor: 9.306

3.  Management of priapism in adult men.

Authors:  Onyeanunam N Ekeke; Hannah E Omunakwe; Ndu Eke
Journal:  Int Surg       Date:  2015-03

Review 4.  First-episode schizophrenia: a focus on pharmacological treatment and safety considerations.

Authors:  Deanna L Kelly; Robert R Conley; William T Carpenter
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Sex differences, hormones, and fMRI stress response circuitry deficits in psychoses.

Authors:  Jill M Goldstein; Katie Lancaster; Julia M Longenecker; Brandon Abbs; Laura M Holsen; Sara Cherkerzian; Susan Whitfield-Gabrieli; Nicolas Makris; Ming T Tsuang; Stephen L Buka; Larry J Seidman; Anne Klibanski
Journal:  Psychiatry Res       Date:  2015-03-31       Impact factor: 3.222

Review 6.  Drug-induced male sexual dysfunction. An update.

Authors:  G B Brock; T F Lue
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

Review 7.  Pitfalls and problems of the long term use of neuroleptic drugs in schizophrenia.

Authors:  M F Bristow; S R Hirsch
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

8.  A Qualitative Study on Sexuality and Sexual Experiences in Community Forensic Mental Health Patients in Queensland, Australia.

Authors:  Elnike Brand; Dinesh Nagaraj; Angela Ratsch; Edward Heffernan
Journal:  Front Psychiatry       Date:  2022-03-31       Impact factor: 4.157

9.  Identifying and treating the prodromal phases of bipolar disorder and schizophrenia.

Authors:  Susan Conroy; Michael Francis; Leslie A Hulvershorn
Journal:  Curr Treat Options Psychiatry       Date:  2018-01-22

10.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.